Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Penny Stocks

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

X4 Pharma Highlights New Data Supporting Mavorixafor’s Broad Potential In Chronic Neutropenia

By Vandana Singh
September 27, 10:49 AM
X4 Pharmaceuticals Inc (NASDAQ:XFOR) announced new data from its Phase 1b trial evaluating the ability of its lead clinical candidate, mavorixafor,…

XFOR

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Ocular Therapeutix’s Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea

By Vandana Singh
September 27, 10:21 AM
Ocular Therapeutix Inc (NASDAQ:OCUL) announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration…

OCUL

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

What’s Going On With Velodyne Lidar Shares

By Henry Khederian
September 27, 10:16 AM
Velodyne Lidar Inc (NASDAQ: VLDR) shares are trading higher by 3.12% to $0.99 Tuesday morning after the company signed a multi-year agreement to provide its lidar sensors to Stanley Robotics. What Else?

VLDR

Read More
2 minute read
  • Penny Stocks

Short Volatility Alert: Good Gaming, Inc.

By Christopher Sappo
September 27, 9:53 AM
On Monday, shares of Good Gaming, Inc. (OTC: GMER) experienced volatile short activity. After the activity, the stock price went down -6.40% to $.0625. The overall sentiment for GMER has been Neutral.

GMER

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Aquestive’s AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction

By Vandana Singh
September 27, 9:35 AM
Aquestive Therapeutics Inc (NASDAQ:AQST) announced positive topline results from the EPIPHAST 2 trial for its AQST-109 epinephrine sublingual film. The trial…

AQST

Read More
6 minute read
  • Biotech
  • Cryptocurrency
  • General
  • Health Care
  • IPOs
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • Movers
  • News
  • Penny Stocks
  • Social Media
  • Tech
  • Top Stories
  • Trading Ideas

Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify’s Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27

By Vandana Singh
September 27, 8:46 AM
Bloomberg

AAPL

Read More
1 minute read
  • News
  • Penny Stocks
  • Tech

Warren Buffett-Backed EV Maker Joins Hands With Aurora Mobile To Drive Reach In Europe

By Anusuya Lahiri
September 27, 8:40 AM
Aurora Mobile Limited (NASDAQ:JG) agreed to help Warren Buffett’s Berkshire Hathaway (NYSE: BRK-B) -backed BYD Co, Ltd (OTC:BYDDF) expand its new energy vehicle business in…

BRK-B

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

The Parent Company Completes The Acquisition Of Calma Cannabis Dispensary

By Vuk Zdinjak
September 27, 7:59 AM
TPCO Holding Corp., (OTCQX: GRAMF) (NEO:GRAM.U) has acquired the remaining 15% equity of its Calma Weho LLC dispensary following receipt of all necessary regulatory approvals.

GRAMF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Canopy’s BioSteel Taps Another Professional Athlete – Soccer Star Alphonso Davies

By Vuk Zdinjak
September 27, 7:49 AM
BioSteel Sports Nutrition Inc., which is majority owned by Canopy Growth Corporation (NASDAQ: CGC) signed international soccer star Alphonso Davies to its growing team of athlete partners.

CGC

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Snap To Surge Around 20%? Here Are 5 Other Price Target Changes For Tuesday

By Lisa Levin
September 27, 7:09 AM
Piper Sandler raised Snap Inc. (NYSE: SNAP) price target from $11 to $12. Piper Sandler analyst Thomas Champion maintained the stock with a Neutral. Snap shares fell 1.4% to close at $10.18 on Monday.

DPZ

Posts pagination

Previous 1 … 1,042 1,043 1,044 … 1,231 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service